Inactive Instrument
Quotes DiaMedica Inc. Toronto S.E.
Stocks
DMA
CA25253T1075
Biotechnology & Medical Research
|
End-of-day quote
Toronto S.E.
|
||
| - CAD | - |
|
| 08-11 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-11 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Basic data
Market Cap (CAD)
490,873,055
Market Cap (USD)
355,370,343
Net sales (CAD)
0
Net sales (USD)
0
Free-Float
56.63 %
Free-Float capitalization (CAD)
277,968,073
Free-Float capitalization (USD)
201,236,569
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 355M | |
| -0.94% | -0.71% | +45.60% | +103.25% | 68.52B | |
| -1.06% | -6.18% | +30.53% | +74.09% | 62.88B | |
| +3.13% | +1.71% | -12.50% | +390.48% | 28.13B | |
| -2.74% | -6.31% | +26.33% | +11.24% | 25.56B | |
| -0.54% | -5.47% | -3.88% | -18.31% | 24.65B | |
| -1.94% | -4.73% | +18.32% | -19.25% | 19.81B | |
| -4.27% | +3.07% | +211.22% | +362.48% | 17.69B | |
| -1.37% | -4.51% | -5.21% | +507.43% | 14.66B | |
| +1.14% | -0.34% | +52.38% | +163.82% | 14.45B | |
| Average | -0.95% | -1.63% | +40.31% | +175.03% | 27.67B | |
| Weighted average by Cap. | -0.88% | -1.87% | +36.37% | +138.92% |
Historical Quotes: DiaMedica Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- DMAC Stock
- DMA Stock
- Quotes DiaMedica Inc.
Select your edition
All financial news and data tailored to specific country editions
